Article Text

Download PDFPDF

One size does not fit all: preventing tuberculosis among child contacts
  1. Daria Szkwarko1,2,
  2. Yael Hirsch-Moverman3,4
  1. 1Department of Family Medicine, The Warren Alpert School of Medicine at Brown University, Providence, Rhode Island, USA
  2. 2Department of Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  3. 3ICAP at Columbia University, New York City, New York, USA
  4. 4Department of Epidemiology, Mailman School of Public Health, New York City, New York, USA
  1. Correspondence to Dr Daria Szkwarko; szkwarkd{at}gmail.com

Statistics from Altmetric.com

Summary box

  • Tuberculosis (TB) preventive treatment (TPT) is highly effective at preventing TB cases and deaths in children, yet only a quarter of children eligible for TPT globally receive it.

  • The WHO roadmap for childhood TB recommends an ‘integrated, family and community-centered strategy,’ yet, there is no clear guidance on how to operationalise such a strategy and common strategies may not serve all the diverse needs of unique families whose children are in need of TB prevention services.

  • This article presents a flexible child contact management (CCM) framework, which goes beyond the traditional approaches of either facility-based or community-based, and can be customised for each child and their family’s needs.

  • Strengthening the WHO health system building blocks, such as health information systems and health service delivery, could help provide infrastructure and support for a flexible CCM framework.

Introduction

The United Nations General Assembly high-level meeting (HLM) on Ending TB in 2018 brought government leaders and other stakeholders together to highlight the urgent need to address tuberculosis (TB), the leading infectious disease killer worldwide.1 In advance of the HLM, the WHO and other organisations, released updated guidance on preventing and treating childhood TB.2 The HLM outcome was encouraging with>100 countries agreeing to provide 30 million people with TB preventive treatment (TPT), including 4 million young children (<5 years), by the end of 2022.

Tuberculosis is particularly deadly for children. In 2018, an estimated 1.1 million children developed TB and >2 00 000 children died.3 7.5 million are exposed to TB at the household level and are in need of TB evaluation and TPT to avert TB disease.3 4 Young children are particularly vulnerable, and are at risk for disseminated and severe forms of TB.5 In 2016, in recognition of the importance of preventing TB among young children, the WHO added TPT initiation for eligible child contacts as an indicator to be collected by countries globally.

TPT is highly effective at preventing TB in all ages.6 A modelling study demonstrated that preventing one child TB death would require visiting 48 households where an adult with TB resides, screening 77 children, providing 48 TPT and two TB treatment courses.7 Unfortunately, WHO estimates that only 27% of the 1.3 million TB-exposed young children initiated TPT in 2018, and studies suggest that the number of exposed young children is likely higher.3 4 8

Effective TB prevention among young children requires implementation of successful child TB contact management, which entails identifying and screening child contacts exposed to adults with TB, and ensuring initiation and completion of either TPT or TB treatment. National TB programme (NTPs) recommend that healthcare workers (HCWs) use standardised child contact management (CCM) approaches to facilitate delivery of all cascade services/steps. The traditional CCM approach is facility-based, where all CCM cascade steps are conducted at the health facility.9 10 An alternative approach aims to provide CCM services in the community (in households or community centres).11 12 At times, a combination of both approaches is implemented where for example, identification and symptom screening occur in the community and evaluation and treatment happen at the facility.13 14 Standardised approaches coupled with renewed interest in childhood TB and WHO reporting requirements have led to some improvement in TPT initiation among TB-exposed young children globally from 13% in 2016 to 27% in 2018.3 15 Despite this improvement, TPT initiation remains suboptimal due to many CCM implementation challenges in low-resource, high TB incidence countries that jeopardise its success.

Barriers to child contact management

In 2017, a systematic review studied CCM barriers in high TB burden countries. Individual barriers include knowledge gaps (both among family members and HCWs), access-to-care, stigma, competing priorities and treatment-related challenges; health system barriers include health system infrastructure such as lack of government/NTP prioritisation, limited staff resources, and lack of tools to support monitoring and evaluation.16 These challenges create losses at every CCM cascade step, from identification of child contacts, to TB evaluation, TPT initiation, and TPT completion. Interestingly, although many of the above barriers were described as individual barriers, some are a direct result of inflexible and underfunded health systems that do not prioritise patients’ needs. Furthermore, barriers are inter-related and often stem from broader systemic issues like poverty and education inequality. For example, if we consider access-to-care, a child may be unable to access care because while their caregiver is worried about stigma associated with a HCW visiting the household, they lack funds to bring the child to the facility. Stigma may exist due to lack of prioritisation of community and HCW education. For another child, their caregiver may be more worried about stigma when visiting a facility despite being able to afford transport to bring a child in for evaluation. A standardised framework in this one community may not serve the diverse needs of children in need of TB prevention services.

In order to continue an upward trajectory of TPT initiation, it is crucial to recognise that barriers that impede successful CCM vary from family to family, even within the same community. A pilot study from Lesotho demonstrated that caregivers were interested in being involved in their children’s treatment decisions.17 The WHO roadmap for childhood TB recommends an ‘integrated, family and community-centred strategy’.2 Yet, there is no clear guidance on how health systems can operationalise such a strategy. We propose a flexible CCM framework, which goes beyond standardised approaches and provide suggestions on how health systems could support a framework that is customised for each child’s/family’s needs.

Flexible CCM framework

The premise of this framework is that ‘one size does not fit all’. Thus, we propose that health systems and NTPs train HCWs to accomplish each CCM cascade step depending on the child’s/family’s unique circumstances. Traditionally, the majority of NTPs encourage that child contacts move through the CCM cascade in a structured fashion. In a flexible CCM framework, each child contact would flow through each CCM cascade step based on their family’s needs. A flexible approach to identification could begin in the facility with a family-centred discussion with the adult with TB using a shared-decision making approach. If the child can be brought to the facility, the HCW would invite them to come in for screening. If the child cannot come to the facility, the HCW would visit the household. A flexible approach to screening would depend on the health system’s capacity as well as a family-centred discussion. In most areas, symptomatic child contacts would need to report to the facility to finish the screening process due to limited availability of mobile x-ray. Asymptomatic child contacts would be screened via history and physical examination in the facility or community. Once active TB disease has been ruled out, TPT would be initiated. A flexible approach to TPT initiation would include a family-centred discussion and shared-decision making. If TPT provision is made available in both the facility and the community, both options would be presented to the family, and TPT would need to be available at both facility and community levels. Follow-up of child contacts on TPT can occur in the facility or the community based on family’s preferences. (figure 1, table 1)

Figure 1

A flexible CCM framework. CCM, child contact management; TB, tuberculosis; TPT, TB preventive treatment.

Table 1

A child contact’s journey through the CCM cascade in commonly available models and an example of challenges that could be overcome by a flexible model

Health system strengthening for a flexible CCM framework

For health systems to support a flexible CCM framework, a broader effort to strengthen and monitor health systems is needed. The WHO describes six core building blocks for health systems strengthening.18 In particular, strengthening two of these components, health information systems and health service delivery, could lead to an improved infrastructure that would support person-centred strategies such as a flexible CCM framework.

Health information systems strengthening incorporates enhancing access of information to diverse users throughout the health system so it is reliable, accessible, and comprehensible. It also includes monitoring and evaluating data related to supply chain so that X-ray availability or TPT drug supply would be routinely tracked and communicated to HCWs to decrease evaluation barriers and stock-outs. Expansion and integration of electronic health record systems can enable all aspects of care to be tracked everywhere—in facilities or communities. Therefore, a HCW seeing a child in an outpatient clinic for a skin infection should be able to easily see electronically that this child has been identified as potentially eligible for TPT at a nearby facility.

Health service delivery incorporates service quality which ultimately integrates staff training. Longitudinal training and mentorship for HCWs could occur using less expensive telementoring modalities like the ECHO modelTM that increase HCW knowledge and patient access-to-care.19 Additionally, a person-centeredness approach, that is, services that are organised around the person rather than disease or financing, is recommended. The WHO has a framework for integrated people-centered health services.20 Person-centered care is oriented toward addressing patients’ priorities as a holistic model of healthcare delivery that considers the patient as the central figure in the process/continuum of care. Thus a person-centred approach is not a one size fits all solution to the multifactorial barriers that have been identified, but rather a flexible model of care that reacts to the specialised needs of individuals.16

Conclusion

Given the significant burden of TB disease in young children, the continued challenges in diagnosing TB in children, and its severe sequelae,4 21 TB prevention is a salient public health issue. Moving beyond traditional CCM constructs is critically important given that every individual, family, community, facility, TB programme, and country vary greatly. Therefore, the CCM journey for each adult with TB and their child contacts should be family-centred and flexible. CCM barriers that appear to be individually-based are often a result of larger, systemic issues and vary greatly. It is imperative that health systems consider an individual family’s unique CCM barriers and meet the child/family where they are. Using existing frameworks for broader health system strengthening and integrated people-centred care can support a flexible CCM model. Implementing a flexible CCM framework that incorporates shared-decision making between HCWs and families at every step may enhance efforts to increase TB preventive services and decrease TB burden in vulnerable children.

Acknowledgments

Wafaa El-Sadr, E. Jane Carter, Karen du Preez.

References

Footnotes

  • Handling editor Seye Abimbola

  • Contributors DS and YH-M contributed equally to the conception, writing and editing of this manuscript. E. Jane Carter, Wafaa El-Sadr and Karen Du Preez provided technical editing for this manuscript.

  • Funding YH-M was funded by the National Institutes on Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) (K01AI104351). DS is partially supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Clinical and Translational Research (Advance-CTR). DS is also partially supported by the Thrasher Research Fund.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institutes of Health and the Thrasher Research Fund.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data is not available.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.